Egnyte Releases Quality Document Management Offering
Egnyte announced a new product for emerging life sciences companies to manage regulated documentation. Egnyte for Life Sciences Quality is a GxP-compliant product that digitizes the lifecycle of regulated documents, like standard operating procedures (SOPs) and training records. Egnyte for Life Sciences Quality is the third product in a growing lineup of offerings, following the release of Egnyte for Life Sciences in November 2020 and new review and approval workflows.
Egnyte for Life Sciences Quality enables Life Sciences companies to:
- Meet GxP & FDA 21 CFR Part 11
- Perform e-Signatures: sign off on documents, like SOPs and clinical trial protocols, in a compliant manner, without needing third-party plugins.
- Manage effective documents: as new versions are approved, Quality teams can define version numbers for new drafts, set expiry dates, and ensure only effective copies are available.
- Scale compliance processes quickly: built with best practices gleaned from 17,000 global customers, Egnyte for Life Sciences Quality implements and validates as it integrates with existing IT infrastructure.
- Support for multiple departments and use cases: designed with the ability to support training, continuity, and site readiness documentation.
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
